BIOMAT Database Logo BIOMAT Database Logo

Development of Bis-cyclic Imidazolidine-4-one Derivatives as Potent Antibacterial Agents. 2020

Minghui Wang, and Ruixuan Gao, and Mengmeng Zheng, and Peng Sang, and Chunpu Li, and En Zhang, and Qi Li, and Jianfeng Cai
Department of Chemistry, University of South Florida, 4202 E. Fowler Ave, Tampa, Florida 33620, United States.

Antibiotic resistance has emerged as one of the biggest public health concerns all over the world. In an effort to combat bacterial infections, a series of imidazolidine-4-one derivatives with potent and broad-spectrum antibacterial activity and low rates of drug resistance were developed by mimicking the salient physiochemical features of host defense peptides. These small molecules displayed potent activity against both Gram-negative and Gram-positive bacteria including several multidrug-resistant bacteria strains. Meanwhile, time-kill kinetics and drug resistance studies suggested that the most potent compound 3 could not only eliminate the bacteria rapidly but also exhibit a low probability of drug resistance in MRSA over many passages. Further mechanistic studies suggested that 3 eradicated bacterial pathogens by disintegrating membranes of both Gram-negative and Gram-positive bacteria. Together with their small molecular weight and low production cost compared with HDPs, these imidazolidine-4-one compounds may be developed into a new generation of antibiotic therapeutics combating emergent drug resistance.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D003500 Cyclization Changing an open-chain hydrocarbon to a closed ring. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Cyclizations
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D048289 Imidazolidines Compounds based on reduced IMIDAZOLINES which contain no double bonds in the ring. Imidazolidine
D018441 Biofilms Encrustations formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedded in an EXTRACELLULAR POLYMERIC SUBSTANCE MATRIX that is secreted by the microbes. They occur on body surfaces such as teeth (DENTAL DEPOSITS); inanimate objects, and bodies of water. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and anti-fouling agents. Biofilm
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

Minghui Wang, and Ruixuan Gao, and Mengmeng Zheng, and Peng Sang, and Chunpu Li, and En Zhang, and Qi Li, and Jianfeng Cai
Novel bis-cyclic guanidines as potent membrane-active antibacterial agents with therapeutic potential.
October 2017, Chemical communications (Cambridge, England),
Minghui Wang, and Ruixuan Gao, and Mengmeng Zheng, and Peng Sang, and Chunpu Li, and En Zhang, and Qi Li, and Jianfeng Cai
Facilely accessible quinoline derivatives as potent antibacterial agents.
July 2018, Bioorganic & medicinal chemistry,
Minghui Wang, and Ruixuan Gao, and Mengmeng Zheng, and Peng Sang, and Chunpu Li, and En Zhang, and Qi Li, and Jianfeng Cai
Discovery of novel pleuromutilin derivatives as potent antibacterial agents.
July 2022, European journal of medicinal chemistry,
Minghui Wang, and Ruixuan Gao, and Mengmeng Zheng, and Peng Sang, and Chunpu Li, and En Zhang, and Qi Li, and Jianfeng Cai
Development of cannabidiol derivatives as potent broad-spectrum antibacterial agents with membrane-disruptive mechanism.
February 2024, European journal of medicinal chemistry,
Minghui Wang, and Ruixuan Gao, and Mengmeng Zheng, and Peng Sang, and Chunpu Li, and En Zhang, and Qi Li, and Jianfeng Cai
Azole Derivatives: Recent Advances as Potent Antibacterial and Antifungal Agents.
January 2023, Current medicinal chemistry,
Minghui Wang, and Ruixuan Gao, and Mengmeng Zheng, and Peng Sang, and Chunpu Li, and En Zhang, and Qi Li, and Jianfeng Cai
4-amino bis-pyridinium derivatives as novel antileishmanial agents.
July 2014, Antimicrobial agents and chemotherapy,
Minghui Wang, and Ruixuan Gao, and Mengmeng Zheng, and Peng Sang, and Chunpu Li, and En Zhang, and Qi Li, and Jianfeng Cai
Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
August 2019, European journal of medicinal chemistry,
Minghui Wang, and Ruixuan Gao, and Mengmeng Zheng, and Peng Sang, and Chunpu Li, and En Zhang, and Qi Li, and Jianfeng Cai
Alkyl-linked bis-THTT derivatives as potent in vitro trypanocidal agents.
March 2006, Bioorganic & medicinal chemistry letters,
Minghui Wang, and Ruixuan Gao, and Mengmeng Zheng, and Peng Sang, and Chunpu Li, and En Zhang, and Qi Li, and Jianfeng Cai
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
June 2000, Journal of medicinal chemistry,
Minghui Wang, and Ruixuan Gao, and Mengmeng Zheng, and Peng Sang, and Chunpu Li, and En Zhang, and Qi Li, and Jianfeng Cai
Enols as potent antibacterial agents.
November 2001, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!